Skip to content

Topic

Dwayne Johnson The rock

Latest Daily Tribune news and analysis on Dwayne Johnson The rock.

  1. J&J charts $2.58-B course

    J&J charts $2.58-B course

    Johnson & Johnson is partnering with Sail Biomedicines to advance in vivo CAR-T treatments for immune-mediated diseases, with an exclusive $2.58 billion…